Hyperfine, Inc. (HYPR): Shareholders' Equity
$41.01M
As of 2025-12-31
$36.76M
As of 2026-06-30
-30.8%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.01M | -16.4% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $49.04M | -41.9% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $84.40M | -31.8% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $123.72M | -33.6% | 2025-03-17, Balance as of period end |
| 2021-12-31 | $186.23M | n/m | 2023-03-22, Balance as of period end |
| 2020-12-31 | -$61.05M | n/a | 2022-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $41.01M | -16.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $13.26M | n/m |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $1.92M | +5.8% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $6.45M | n/m |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $12.26M | +21.8% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.62M | -59.8% |
| electroCore, Inc. (ECOR) | 2025-12-31 | -$1.71M | n/m |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $13.48M | +121.7% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.40M | +64.4% |
Compare HYPR, CV, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗